Xeris Biopharma Holdings (XERS) Shareholder's Equity (2020 - 2026)
Xeris Biopharma Holdings (XERS) Shareholder's Equity (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.21 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 446.17 Mn |
| 10 | Xeris Biopharma Holdings | 1.07 Bn | 954.87 Mn | 72.55 Mn | 13.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.01 Mn |
| Dec 31, 2025 | 13.69 Mn |
| Sep 30, 2025 | -861,000.00 |
| Jun 30, 2025 | -19.30 Mn |
| Mar 31, 2025 | -35.13 Mn |
| Dec 31, 2024 | -29.62 Mn |
| Sep 30, 2024 | -28.32 Mn |
| Jun 30, 2024 | -19.29 Mn |
| Mar 31, 2024 | -9.18 Mn |
| Dec 31, 2023 | -6.78 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 13.64 Mn |
| Mar 31, 2023 | 30.05 Mn |
| Dec 31, 2022 | 45.19 Mn |
| Sep 30, 2022 | 55.04 Mn |
| Jun 30, 2022 | 73.94 Mn |
| Mar 31, 2022 | 96.46 Mn |
| Dec 31, 2021 | 95.23 Mn |
| Sep 30, 2021 | -2.46 Mn |
| Jun 30, 2021 | 19.89 Mn |